Table 2.
CP (n = 88) % |
SP (n = 87) % |
χ2 | P | AOR (95% CI) |
P | |
---|---|---|---|---|---|---|
Pain location | 35.6 | <0.001 | ||||
Back | 84 | 72 | 2.3 (0.9–5.3) | 0.06 | ||
Shoulder | 33 | 20 | 2.9 (1.3–6.6) | 0.01 | ||
Pelvis | 10 | 2 | 6.7 (1.1–39.9) | 0.04 | ||
Hands | 9 | 3 | 4.3 (0.8–22.8) | 0.08 | ||
Feet | 13 | 12 | 1.3 (0.4–4.2) | 0.71 | ||
Stomach | 16 | 31 | 0.4 (0.1–0.9) | 0.03 | ||
Head | 19 | 23 | 1.0 (0.4–2.6) | 0.95 | ||
Face | 2 | 3 | 0.9 (0.1–9.5) | 0.93 | ||
Legs | 48 | 47 | 1.4 (0.7–2.8) | 0.42 | ||
Arms | 6 | 15 | 0.1 (0.03–0.5) | 0.005 | ||
Other | 25 | 18 | 1.7 (0.7–3.9) | 0.21 | ||
CP (n = 88) % |
SP (n = 87) % |
χ2 | P | AOR (95% CI) |
P | |
Pain genesis | 48.2 | <0.001 | ||||
Accident | 57 | 25 | 6.2 (2.1–18.1) | 0.001 | ||
Surgery | 11 | 6 | 1.8 (0.4–8.4) | 0.45 | ||
Nerve damage | 21 | 2 | 15.7 (2.9–84.5) | 0.001 | ||
Arthritis | 11 | 1 | 5.9 (0.5–67.3) | 0.15 | ||
HIV | 0 | 0 | -- | -- | ||
Cancer | 0 | 0 | -- | -- | ||
Don’t know | 21 | 23 | 2.8 (0.8–9.5) | 0.10 | ||
Other | 19 | 46 | 0.7 (0.2–2.2) | 0.58 | ||
Pain-related Substance Use in Past Week | 17.1 | 0.10 | ||||
More than prescribed opiate medication | 33 | 18 | 1.5 (0.6–3.4) | 0.35 | ||
Somebody else’s opiate pain medication | 61 | 45 | 1.6 (0.8–3.3) | 0.19 | ||
Heroin | 39 | 33 | 1.1 (0.5–2.2) | 0.88 | ||
CP (n = 88) % |
SP (n = 87) % |
χ2 | P | AOR (95% CI) |
P | |
Street methadone | 15 | 9 | 1.1 (0.4–3.2) | 0.89 | ||
More than prescribed non-opiate medication | 11 | 3 | 2.0 (0.4–9.7) | 0.38 | ||
Somebody else’s non-opiate medication | 13 | 7 | 0.9 (0.3–3.6) | 0.95 | ||
More than prescribed benzodiazepine medication | 11 | 5 | 1.5 (0.3–7.0) | 0.59 | ||
Somebody else’s benzodiazepine medication | 14 | 5 | 1.6 (0.3–7.3) | 0.55 | ||
Other street drugs | 36 | 24 | 1.5 (0.6–3.5) | 0.34 | ||
Alcohol | 24 | 25 | 0.5 (0.2–1.2) | 0.13 |
CP = Chronic pain, SP = Some pain, AOR = Adjusted odds ratio.
Controlling for age.